MannKind Corporation · 1 day ago
Business Development Internship
MannKind Corporation is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. The Business Development Internship offers hands-on experience in market analysis and strategic planning within the pharmaceutical industry, allowing interns to gain exposure to business development frameworks and develop high-value analytical skills.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Landscape assessments for cardiovascular (CV) and chronic kidney disease (CKD) therapeutic areas
Competitive analysis and market trend evaluation
Global expansion assessments for MannKind’s commercial products
Development of strategic insights and business cases for BD initiatives
Projects will be assigned based on business priorities and intern skill set
Qualification
Required
Currently pursuing a Bachelor's or Master's degree in Business, Life Sciences, or a related field
Commit to working 40 hours per week for the full 10 weeks without vacation
A reliable commute or the intention to find temporary housing before starting the internship is required
At this time, we are only able to consider candidates who do not require visa sponsorship, including those with a student visa
Preferred
Preferably within 1-2 years of graduation
Strong analytical and research skills
Proficiency in Microsoft Excel and PowerPoint
Excellent attention to detail and ability to work independently
Excellent written and verbal communication skills
Interest in healthcare, pharmaceuticals, and strategic planning
Ability to work independently and manage multiple tasks in a fast-paced environment
Strong written and verbal communication skills
Self-motivated and demonstrated learning agility
You take the initiative to identify opportunities for improvement and act on them without needing constant direction
You are open to constructive criticism and use it to improve performance and grow professionally
Company
MannKind Corporation
MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions.
Funding
Current Stage
Public CompanyTotal Funding
$475MKey Investors
Blackstone GroupDeerfield Capital Management
2025-08-06Post Ipo Debt· $75M
2021-03-02Post Ipo Debt· $200M
2018-12-01Post Ipo Equity· $40M
Recent News
2026-01-09
GlobeNewswire
2025-12-24
2025-12-24
Company data provided by crunchbase